TREMFYA
Active substance: guselkumab
INJECTION · GUSELKUMAB 200 mg/20mL
United StatesActive
Marketing holder: Janssen Biotech, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
Composition
- GUSELKUMAB · 200 mg/20mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 3 |
|
| EU 1 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-41aa-7e48-b29e-f000151cac04,01a120c3-e8c8-712e-b2cc-0dd6e2698f0c,01a120c5-29c5-7122-9631-364e3b19b2bc;count=3 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-4a64-7c3e-833c-a051e6f8d7a2,01a12096-57f3-79b4-b216-761f35dc00c6,01a1209d-96b1-7034-8582-cf5ffe41eb89;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 57894-650
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 57894-650 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 57894-650 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 57894-650 · Verified 2026-10-09 · open in source